Cite
Maillard A, Redjoul R, Klemencie M, et al. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients. Blood. 2022;139(1):134-137doi: 10.1182/blood.2021014232.
Maillard, A., Redjoul, R., Klemencie, M., Labussière Wallet, H., Le Bourgeois, A., D'Aveni, M., Huynh, A., Berceanu, A., Marchand, T., Chantepie, S., Botella Garcia, C., Loschi, M., Joris, M., Castilla-Llorente, C., Thiebaut-Bertrand, A., François, S., Leclerc, M., Chevallier, P., & Nguyen, S. (2022). Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients. Blood, 139(1), 134-137. https://doi.org/10.1182/blood.2021014232
Maillard, Alexis, et al. "Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients." Blood vol. 139,1 (2022): 134-137. doi: https://doi.org/10.1182/blood.2021014232
Maillard A, Redjoul R, Klemencie M, Labussière Wallet H, Le Bourgeois A, D'Aveni M, Huynh A, Berceanu A, Marchand T, Chantepie S, Botella Garcia C, Loschi M, Joris M, Castilla-Llorente C, Thiebaut-Bertrand A, François S, Leclerc M, Chevallier P, Nguyen S. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients. Blood. 2022 Jan 06;139(1):134-137. doi: 10.1182/blood.2021014232. PMID: 34818411; PMCID: PMC8616709.
Copy
Download .nbib